Featured Research

from universities, journals, and other organizations

New biomarker holds promise for monitoring heart disease

Date:
March 11, 2014
Source:
Baylor Health Care System
Summary:
A special newly discovered biomarker, “Gb3,” potentially related to the survival of heart disease patients, could change the way the country’s No. 1 killer is monitored in the future. The study found that patients with a higher level of the urinary lipid globotriaosylceramide (Gb3) may be at greater risk for near-term death as a result of heart disease. The presence of elevated urinary Gb3, along with other lipids, indicated for the first time that heart disease is linked to lipid abnormalities in organs outside of the heart in patients with common forms of heart disease.

A special newly discovered biomarker, "Gb3," potentially related to the survival of heart disease patients, could change the way the country's No. 1 killer is monitored in the future, according to research published in the Feb. 4 edition of the Journal of the American Heart Association (JAHA).

Led by principal investigator Raphael Schiffmann, MD, (Director of Baylor's Institute for Metabolic Disease, part of Baylor Research Institute), the study found that patients with a higher level of the urinary lipid globotriaosylceramide (Gb3) may be at greater risk for near-term death as a result of heart disease. The presence of elevated urinary Gb3, along with other lipids, indicated for the first time that heart disease is linked to lipid abnormalities in organs outside of the heart in patients with common forms of heart disease.

Originally, the trial was designed as a screening study for Fabry disease, a rare genetic condition that triggers heart complications. Investigators performed urinary analyses in search of elevated Gb3 levels, which is common in Fabry disease patients.

"To our surprise, we noticed after a few months that some heart disease patients who did not have Fabry disease did have elevated Gb3 in the urine," Dr. Schiffmann said. "Simultaneously, we also found that some of those patients had died in the short interval that had passed since we had last seen them for this screening study."

With excellent statistical support, Dr. Schiffmann and his team then found that heart disease patients with higher Gb3 levels face a higher risk of death, compared to those without elevated volumes of the lipid in their urine.

"This was a very surprising, yet encouraging, discovery, given the fact that Gb3 elevation was -- until now -- thought to be the exclusive hallmark of Fabry disease," Dr. Schiffmann said. "Remarkably, this biomarker is significantly different from existing ones and could be of great significance for the future study of heart disease."

Dr. Schiffmann added that continued research is needed in order to fully explore Gb3 and other lipids as heart disease biomarkers. The research was performed as a result of collaboration between Baylor's cardiology network through Baylor Health Care System and the Institute of Metabolic Disease.


Story Source:

The above story is based on materials provided by Baylor Health Care System. Note: Materials may be edited for content and length.


Journal Reference:

  1. R. Schiffmann, S. Forni, C. Swift, N. Brignol, X. Wu, D. J. Lockhart, D. Blankenship, X. Wang, P. A. Grayburn, M. R. G. Taylor, B. D. Lowes, M. Fuller, E. R. Benjamin, L. Sweetman. Risk of Death in Heart Disease is Associated With Elevated Urinary Globotriaosylceramide. Journal of the American Heart Association, 2014; 3 (1): e000394 DOI: 10.1161/JAHA.113.000394

Cite This Page:

Baylor Health Care System. "New biomarker holds promise for monitoring heart disease." ScienceDaily. ScienceDaily, 11 March 2014. <www.sciencedaily.com/releases/2014/03/140311184633.htm>.
Baylor Health Care System. (2014, March 11). New biomarker holds promise for monitoring heart disease. ScienceDaily. Retrieved July 24, 2014 from www.sciencedaily.com/releases/2014/03/140311184633.htm
Baylor Health Care System. "New biomarker holds promise for monitoring heart disease." ScienceDaily. www.sciencedaily.com/releases/2014/03/140311184633.htm (accessed July 24, 2014).

Share This




More Health & Medicine News

Thursday, July 24, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

New Painkiller Designed To Discourage Abuse: Will It Work?

New Painkiller Designed To Discourage Abuse: Will It Work?

Newsy (July 24, 2014) The FDA approved Targiniq ER on Wednesday, a painkiller designed to keep users from abusing it. Like any new medication, however, it has doubters. Video provided by Newsy
Powered by NewsLook.com
Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Newsy (July 24, 2014) Sheik Umar Khan has treated many of the people infected in the Ebola outbreak, and now he's become one of them. Video provided by Newsy
Powered by NewsLook.com
Condemned Man's US Execution Takes Nearly Two Hours

Condemned Man's US Execution Takes Nearly Two Hours

AFP (July 24, 2014) America's death penalty debate raged Thursday after it took nearly two hours for Arizona to execute a prisoner who lost a Supreme Court battle challenging the experimental lethal drug cocktail. Duration: 00:55 Video provided by AFP
Powered by NewsLook.com
China's Ageing Millions Look Forward to Bleak Future

China's Ageing Millions Look Forward to Bleak Future

AFP (July 24, 2014) China's elderly population is expanding so quickly that children struggle to look after them, pushing them to do something unexpected in Chinese society- move their parents into a nursing home. Duration: 02:07 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

    Health News

      Environment News

        Technology News



          Save/Print:
          Share:

          Free Subscriptions


          Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

          Get Social & Mobile


          Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

          Have Feedback?


          Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
          Mobile: iPhone Android Web
          Follow: Facebook Twitter Google+
          Subscribe: RSS Feeds Email Newsletters
          Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins